Exome Asset Management LLC

Name: Exome Asset Management LLC: Form 13F holdings for the quarter ended 2026-06-30
Creator: Listed

An institutional investment manager in NEW YORK, NY. Its Form 13F for the quarter ended Jun 30, 2026, filed Aug 14, 2026. SEC CIK 2011932.

Share this page

Link

Story card, 1080 × 1920

Reported value$162.1m
Positions52

Holdings: 52 positions

The filing on sec.gov

As filed, largest first. Reported value is what the manager stated for each position at the quarter end, in US dollars; it is filing data, not a price. Weight is the position's share of the total reported value. Changes compare with the 13F for the quarter ended 2026-03-31.

Exome Asset Management LLC, holdings
Issuer	Class	CUSIP	Reported value$m	Weight	Shares	Change on the quarter before
Guardant Health IncGH	COM	40131M109	10.1	6.2%	67,500	Reduced−15,236
Praxis Precision Medicines IPRAX	COM NEW	74006W207	9.1	5.6%	27,205	Reduced−18,264
TG Therapeutics IncTGTX	COM	88322Q108	9.1	5.6%	164,915	New+164,915
Cogent Biosciences IncCOGT	COM	19240Q201	8.1	5.0%	210,523	Reduced−68,010
Ionis Pharmaceuticals IncIONS	COM	462222100	7.0	4.3%	88,177	Reduced−21,887
ELI Lilly & CoLLY	COM	532457108	6.6	4.1%	5,492	Reduced−1,520
Abivax SAABVX	SPONSORED ADS	00370M103	6.2	3.9%	46,878	New+46,878
Alumis IncALMS	COM	022307102	5.8	3.5%	204,418	Reduced−74,758
Cytokinetics IncCYTK	COM NEW	23282W605	5.1	3.2%	60,056	Reduced−43,662
Enliven Therapeutics IncELVN	COM	29337E102	5.1	3.1%	100,203	Reduced−119,888
Vera Therapeutics IncVERA	CL A	92337R101	4.2	2.6%	97,276	Reduced−17,715
Unitedhealth Group IncUNH	COM	91324P102	4.0	2.5%	9,612	Reduced−3,250
10X Genomics IncTXG	CL A COM	88025U109	3.9	2.4%	102,629	Reduced−51,565
Natera IncNTRA	COM	632307104	3.7	2.3%	13,800	Reduced−4,850
Uniqure NV	SHS	N90064101	3.7	2.3%	81,056	New+81,056
Rhythm Pharmaceuticals IncRYTM	COM	76243J105	3.6	2.2%	32,209	Reduced−8,372
Maze Therapeutics IncMAZE	COM	578784100	3.4	2.1%	114,692	Added+26,182
Monte Rosa Therapeutics IncGLUE	COM	61225M102	3.3	2.0%	137,115	Reduced−42,369
Moonlake ImmunotherapeuticsMLTX	CLASS A ORD	61559X104	3.2	2.0%	166,493	Reduced−48,883
Alkermes plc	SHS	G01767105	3.2	2.0%	61,336	Reduced−22,767
Liquidia CorporationLQDA	COM NEW	53635D202	3.1	1.9%	39,224	Reduced−6,572
United Therapeutics Corp DelUTHR	COM	91307C102	2.9	1.8%	5,410	Reduced−1,643
Glaukos CorpGKOS	COM	377322102	2.8	1.7%	19,862	Reduced−1,012
Arrowhead Pharmaceuticals inARWR	COM	04280A100	2.6	1.6%	32,214	Reduced−13,507
Agios Pharmaceuticals IncAGIO	COM	00847X104	2.6	1.6%	70,500	Reduced−54,560
Crescent Biopharma Inc.	COM	G2545C104	2.3	1.4%	127,769	Reduced−25,422
Astrazeneca plc	ORD	G0593M107	2.3	1.4%	12,045	New+12,045
Boston Scientific CorpBSX	COM	101137107	2.1	1.3%	48,347	Unchanged
Adagene IncADAG	ADS	005329107	2.1	1.3%	488,293	Reduced−248,552
Penumbra IncPEN	COM	70975L107	2.0	1.2%	6,300	Unchanged
Intuitive Surgical IncISRG	COM NEW	46120E602	2.0	1.2%	4,908	Reduced−1,450
Viking Therapeutics IncVKTX	COM	92686J106	1.9	1.2%	47,861	New+47,861
Ocular Therapeutix IncOCUL	COM	67576A100	1.8	1.1%	181,588	New+181,588
Equillium IncEQ	COM	29446K106	1.8	1.1%	552,956	New+552,956
Ascendis Pharma A/S	ORD SHS	K08588103	1.8	1.1%	6,573	New+6,573
Corbus Pharmaceuticals HoldingsCRBP	COM NEW	21833P301	1.7	1.1%	184,914	Reduced−49,222
Cytomx Therapeutics Inc.CTMX	COM	23284F105	1.7	1.1%	460,067	Reduced−61,401
Verastem IncVSTM	COM NEW	92337C203	1.6	1.0%	429,041	Reduced−207,659
Nektar TherapeuticsNKTR	COM NEW	640268306	1.6	1.0%	22,417	New+22,417
Clearpoint Neuro IncCLPT	COM	18507C103	1.5	0.9%	83,636	New+83,636
Insmed IncINSM	COM PAR $.01	457669307	1.5	0.9%	13,873	Reduced−12,778
Caris Life Sciences IncCAI	COM	142152107	1.4	0.9%	78,180	New+78,180
Bridgebio Pharma IncBBIO	COM	10806X102	1.4	0.8%	18,359	Reduced−49,133
Zenas Biopharma IncZBIO	COM	98937L105	1.3	0.8%	52,443	Reduced−28,287
Novabridge BiosciencesNBP	SPONSORED ADS	44975P103	1.1	0.7%	576,960	Unchanged
Establishment Labs Holdings Inc	COM	G31249108	1.1	0.7%	13,100	Unchanged
Relay Therapeutics IncRLAY	COM	75943R102	0.9	0.5%	47,531	Reduced−230,771
Geron CorpGERN	COM	374163103	0.8	0.5%	624,046	New+624,046
Bright Minds Biosciences IncDRUG	COM NEW	10919W405	0.7	0.4%	10,110	New+10,110
Compass Therapeutics IncCMPX	COM	20454B104	0.6	0.4%	276,165	New+276,165
Replimune Group IncREPL	COM	76029N106	0.4	0.3%	40,361	New+40,361
Arbutus Biopharma CorpABUS	COM	03879J100	0.2	0.1%	50,166	Reduced−25,318

Sold out: 19 positions

Held at the end of the quarter before and not reported this quarter.

Exome Asset Management LLC, positions sold out
Issuer	Class	CUSIP	Weight	Put or call	Change on the quarter before
4D Molecular Therapeutics inFDMT	COM	35104E100	0.0%		Sold out−130,564
Alumis Inc	PUT	022307952	0.0%	Put	Sold out−105,000
Apellis Pharmaceuticals Inc	COM	03753U106	0.0%		Sold out−85,517
Avalo Therapeutics IncAVTX	COM NEW	05338F306	0.0%		Sold out−159,341
Beone Medicines Ltd	CALL	07725L902	0.0%	Call	Sold out−10,000
Centessa Pharmaceuticals plc	PUT	152309950	0.0%	Put	Sold out−34,700
Compass Therapeutics Inc	CALL	20454B904	0.0%	Call	Sold out−25,100
Cytokinetics Inc	PUT	23282W955	0.0%	Put	Sold out−60,000
Elevance Health Inc FormerlyELV	COM	036752103	0.0%		Sold out−14,677
Ideaya Biosciences Inc	CALL	45166A902	0.0%	Put	Sold out−40,000
Ideaya Biosciences Inc	CALL	45166A902	0.0%	Call	Sold out−40,000
Lipocine Inc NewLPCN	COM NEW	53630X203	0.0%		Sold out−60,861
Liquidia Corporation	PUT	53635D952	0.0%	Put	Sold out−40,000
Nextcure IncNXTC	COM NEW	65343E207	0.0%		Sold out−115,500
Palisade Bio IncPALI	COM	696389402	0.0%		Sold out−600,000
Soleno Therapeutics Inc	COM	834203309	0.0%		Sold out−61,673
SPDR Series Trust	STATE STREET SPD	78464A870	0.0%	Put	Sold out−60,000
Travere Therapeutics Inc	PUT	89422G957	0.0%	Put	Sold out−20,000
Wave Life Sciences Ltd	PUT	Y95308955	0.0%	Put	Sold out−30,000

Source: SEC EDGAR, Form 13F-HR, accession 0001420506-26-001714 (on sec.gov). Last ingested by Listed: Oct 22, 2026, 05:26 ET. Listed shows no prices and gives no investment advice.